Diadema Partners »

Legend Biotech 2 Adr Rep Ord shares owned by Diadema Partners

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 69k 21.74

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Legend Biotech 2 Adr Rep Ord

FMR
Suvretta Capital Management
Westfield Capital Management Company
Hillhouse Capital Advisors
Deerfield Management Company
BlackRock
Point72 Asset Management
Artisan Partners Limited Partnership
Goldman Sachs Group
Henderson Group
Alliancebernstein
State Street Corporation
Braidwell
Davern Capital Partners
Matthews International Capital Management

View all funds holding Legend Biotech 2 Adr Rep Ord